01 4AstraZeneca Canada Inc.
01 12165192
02 12475923
03 12506956
04 12506962
01 4Roflumilast
01 4Tablet
01 12014-07-02
02 12023-02-19
03 22023-11-26
Patent Expiration Date : 2023-02-19
Date Granted : 2013-06-18
Brand Name : DAXAS
Patent Number : 2475923
Filing Date : 2003-02-19
Strength per Unit : 500?g
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-02-19
Date Granted : 2013-06-18
Patent Expiration Date : 2014-07-02
Date Granted : 2001-04-24
Brand Name : DAXAS
Patent Number : 2165192
Filing Date : 1994-07-02
Strength per Unit : 500?g
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-07-02
Date Granted : 2001-04-24
Patent Expiration Date : 2023-11-26
Date Granted : 2012-01-03
Brand Name : DAXAS
Patent Number : 2506962
Filing Date : 2003-11-26
Strength per Unit : 500?g
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-11-26
Date Granted : 2012-01-03
Patent Expiration Date : 2023-11-26
Date Granted : 2012-10-02
Brand Name : DAXAS
Patent Number : 2506956
Filing Date : 2003-11-26
Strength per Unit : 500?g
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-11-26
Date Granted : 2012-10-02
LOOKING FOR A SUPPLIER?
